U.S. Hospitality Stock News

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

We wouldn't blame Roblox Corporation ( NYSE:RBLX ) shareholders if they were a little worried about the fact that...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company...

Shareholders of Sigma Lithium Corporation ( NASDAQ:SGML ) may have caught the fact that Marcelo Freire de Paiva...

With a price-to-earnings (or "P/E") ratio of 11.5x Security National Financial Corporation ( NASDAQ:SNFC.A ) may be...

We'd be surprised if Genworth Financial, Inc. ( NYSE:GNW ) shareholders haven't noticed that the Executive VP & General...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Starwood Property Trust, Inc. ( NYSE:STWD ) shareholders will have a reason to smile today, with the analysts making...

Curious whether Saul Centers is a hidden bargain or fairly priced at today's levels? You're in the right place to dig into the numbers behind the market buzz. The stock recently bounced 2.2% over the past week and has edged up 1.1% in the past month, even as its year-to-date performance remains down at -18.6%. Investors have shown renewed interest in Saul Centers following property acquisition news and fresh partnerships that have brought attention to its long-term development plans. These...

Zhen Ding Resources (OTCPK:RBTK) has just shared its third quarter and year-to-date earnings. The company posted a modest net loss for the quarter, but reported net income for the nine months, signaling a shift from last year’s losses. See our latest analysis for Zhen Ding Resources. After months of lackluster trading, Zhen Ding Resources has caught the market’s attention. Its latest earnings shift coincides with a remarkable 1-month share price return of 515.38% and a year-to-date share...

Wondering if TaskUs is undervalued or ready for its next move? You are not alone, as plenty of investors are looking for signals beneath the recent headlines. The stock rose 3.7% in the last week, but has slipped by 20.5% over the past month and is down 32.7% year-to-date. These figures suggest shifting sentiment and risk perceptions around the business. Recently, TaskUs captured attention when it announced a new outsourcing partnership with a major client. This development has piqued...

Zoom Communications (ZM) just posted its Q3 2026 results, reporting revenue of $1.2 billion and basic EPS of $2.05. Over the past year, the company has seen revenue climb from $4.6 billion to $4.8 billion, with EPS rising from $2.86 to $5.26. Margins leaned stronger this quarter, reflecting both the boost from a one-off gain and robust operational execution. See our full analysis for Zoom Communications. Let’s see how these results compare to the popular narratives circulating in the...

Senstar Technologies (SNT) has just reported its Q3 2025 results, posting revenue of $9.5 million and basic EPS of $0.043. Looking at recent trends, the company has seen revenue move from $8.3 million in Q2 2024 to $10.2 million in Q4 2024 before settling at $9.5 million this quarter. Basic EPS over the same period shifted from $0.021 to $0.068 and now $0.043. These results came alongside firm profit margins, setting the tone for how investors may interpret the quality of earnings this...

Jiayin Group (NasdaqGM:JFIN) posted total revenue of ¥1.47 billion and basic EPS of ¥7.34 for the third quarter of 2025, accompanied by a net income of ¥376.49 million. The company has seen revenue move from ¥1.44 billion in Q3 2024 to ¥1.47 billion in Q3 2025, while EPS climbed from ¥5.07 to ¥7.34 over the same period. These results point to expanding margins and a favorable profit backdrop heading into the next reporting cycle. See our full analysis for Jiayin Group. Next up, we’re...

In November 2025, Avidity Biosciences announced the launch of its Managed Access Program for the investigational therapy delpacibart zotadirsen for eligible Duchenne muscular dystrophy (DMD44) patients in the United States, aligning with the FDA on a 2026 accelerated approval submission pathway. This move reflects significant clinical and regulatory progress, as the therapy has earned multiple expedited designations from both U.S. and European regulators. We'll explore how securing FDA...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

As the U.S. stock market experiences a notable upswing with major indexes like the Nasdaq, S&P 500, and Dow Jones Industrial Average showing significant gains entering the Thanksgiving holiday, investors are increasingly attentive to opportunities that may be trading below their estimated value. In such a buoyant environment, identifying stocks that are potentially undervalued can provide investors with strategic entry points to capitalize on broader market optimism while maintaining a focus...

Taiho Oncology, Taiho Pharmaceutical, and Cullinan Therapeutics recently announced the initiation of a rolling New Drug Application submission to the U.S. FDA for accelerated approval of zipalertinib, targeting EGFR exon 20 insertion-mutated non-small cell lung cancer after chemotherapy. This milestone builds on zipalertinib’s Breakthrough Therapy Designation and leverages data from the REZILIENT1 Phase 1/2 trial involving previously treated patients. We'll explore how progress toward FDA...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Hanesbrands (HBI) recently posted modest gains, with shares ticking up about 1% over the past week. Investors are weighing the company's mixed fundamentals as the consumer durables sector undergoes shifts and retail demand trends continue to evolve. See our latest analysis for Hanesbrands. Hanesbrands has seen its share price rebound slightly over the past quarter, but momentum remains mixed after a tough year, with a 1-year total shareholder return of -25.11%. While short bursts of optimism...

It's easy to match the overall market return by buying an index fund. While individual stocks can be big winners...

To the annoyance of some shareholders, Here Group Limited ( NASDAQ:HERE ) shares are down a considerable 29% in the...

The board of Halliburton Company ( NYSE:HAL ) has announced that it will pay a dividend on the 24th of December, with...